Seminar Detail

2-Day Certificate Course in Alzheimer’s Disease and Other Neurocognitive Disorders: Update on Risks, Treatment and Evidence-Based Management of Complex Issues
2-Day Certificate Course in Alzheimer’s Disease and Other Neurocognitive Disorders: Update on Risks, Treatment and Evidence-Based Management of Complex Issues

Where:   ANAHEIM, CA

When:  Monday, December 9, 2019 - Tuesday, December 10, 2019

Credit Card Required for online registration | Contact us to redeem Gift Certificates
Other ways to Register: Call (800) 844-8260 Monday-Friday, 6:30am-10:00pm CST |   Printable Form (fax or mail)
Details

$439.99
Single Registration
*** All prices are shown in US Dollars ***
 
View brochure for CE details
Location

DOUBLETREE SUITES ANAHEIM RESORT
2085 S HARBOR BLVD
ANAHEIM, CA 92802
Phone:  714-750-3000
View Map

Alternate Locations

Student Discounts
If you are a student, please click here for registration information.

Group Discounts
If 5+ staff members from your facility are attending this event, please call (800) 844-8260 to learn more about our special rates.

Military Discount
If you are active or retired military personnel, please click here for registration information and select the Military tab.

In-House Options
If you would like this educational event brought to your facility, please click here for on-site training options.

Course Description:

Alzheimer’s disease and other neurocognitive disorders are disabling health conditions that create daunting challenges to patients, families and clinicians. Are you prepared to manage and anticipate the complex patient needs that emerge when caring for your patients? Have there been times in the past that you wished you had done more …?

Catherine Wollman, DNP, CRNP, GNP-BC, will provide the very latest research about who’s at risk, what’s at stake, and what we can realistically do to manage the impact of neurocognitive disorders. Knowledge and evidence in dementia care are constantly changing. We will focus on the newest science, but also the use of ingenuity and compassion to address the multiple problems facing patients and families. Unique clinical challenges will be reviewed using personal stories and case studies to decide the best pharmacological and non-pharmacological interventions to transform you own practice.

Alzheimer’s disease and other neurocognitive disorders will touch almost all of us personally or professionally. During this intense course, Catherine will provide you with new clinical insights and critical thinking skills so that you won’t need to feel uncertain, frustrated or at risk anymore!
Objectives:

  1. Differentiate cognitive impairments, dementias, neurocognitive disorders and their unique symptoms and trajectories.
  2. Review new DSM5™ changes and updated research on neurocognitive disorders.
  3. Evaluate the current status of dementia research, including new risks, causes and prevention of Alzheimer’s disease.
  4. Summarize screening tools and diagnostic methods for neurocognitive disorders.
  5. Recognize the impact of neurocognitive disorders/dementias on the individual, family, caregivers and healthcare providers.
  6. Develop a comprehensive interdisciplinary plan of care for the patient and family with neurocognitive disorders/dementias.
  7. Synthesize evidence-based interventions for behavioral and psychological symptoms of dementia.
  8. Discuss pharmacologic therapy for neurocognitive disorders/dementias, delirium and depression.
  9. Summarize clinical updates on delirium from prevention and early recognition to effective management.
  10. Examine ethical issues related to neurocognitive disorders including capacity, safety, diagnosis disclosure, palliative and end of life care.
  11. Improve quality of life and outcomes of care for patients and families with neurocognitive disorders/dementias.
  12. Analyze case studies of complex patients with neurocognitive disorders/dementias.
OUTLINE

Neurocognitive Disorders, Dementia and Cognitive Impairment
  • DSM-5™ changes and terminology
  • Aging and neurodegeneration
  • New research related to pathophysiology, diagnosis, risk factors and prevention
Differentiate Neurodegenerative Disorders
  • Alzheimer’s disease
  • Vascular disease
  • Frontotemporal disorder
  • Lewy body disease
  • Traumatic Brain Injury
Update on Delirium
  • Acute or persistent delirium
  • Screening and diagnosis
  • Prevent life threatening consequences
  • Evidence-based medications and treatment
  • Long term consequences
Diagnosis of Neurocognitive Disorders/Dementias
  • Reversible dementia-like disorders and conditions
  • Validated cognitive screening tools
  • New diagnostic criteria and stages of dementia
  • Family response to diagnosis
Pharmacologic Therapies for Neurocognitive Disorders/Dementias
  • Cholinesterase inhibitors
  • NMDA receptor antagonists
  • Antidepressants
  • Antipsychotics and other psychotropic drugs
  • Evaluate new drugs and learn medications to avoid
  • Consider risk, side effects, and efficacy for older adults
Behavioral and Psychological Symptoms of Dementia (BPSD)
  • Vast majority of patients with one or more BPSD
  • Serious negative consequences of untreated behaviors
  • Tools to systematically assess the presence and severity of symptoms
  • Investigation of multiple contributing factors
  • Interdisciplinary creation and evaluation of a treatment plan
Interventions for Common Distressing Behaviors
  • Agitation, anxiety and restlessness that lead to emotional distress and disability
  • Apathy that contributes to poor prognosis and increased mortality
  • Sexually inappropriate behaviors – one of the most distressing behaviors
  • Frustration of changing behaviors over time
Best Practice for Unique Challenges
  • Eliminate pain-inducing factors to diminish behaviors
  • Nutrition and hydration challenges with disease progression
  • Sleep disorders and evidence-based management
  • Depression and effective therapy
  • Psychotic symptoms: Nonpharmacological and pharmacological interventions
Ethical Issues
  • Safety, function and autonomy
  • Comfort and dignity
  • Advance care planning
  • Palliative care and hospice
  • Genetic testing
  • Disclosure of diagnosis
Patient/Family Needs Across the Disease Trajectory
  • Professional and family caregivers
  • Community Resources
Case Studies and Clinical Stories
Target Audience

  • Nurses
  • Nurse Practitioners
  • Physician Assistants
  • PTs and PTAs
  • OTs and OTAs
  • SLPs
  • Social Workers
  • Nursing Home Administrators
  • Mental Health Professionals from Hospitals, Skilled Nursing Facilities, Clinics, Assisted Living Facilities …
  • Anyone desiring next-level skills to proactively assess and intervene for patients with neurocognitive disorders!

M. CATHERINE WOLLMAN, DNP, GNP-BC

M. Catherine Wollman, DNP, GNP-BC, has been a gerontological nurse practitioner for over 25 years, caring for older adults in acute care, long-term care and home care. Catherine has served as the director of senior health for a large hospital system offering a full spectrum of services, including prevention, acute care, and rehabilitation. In this capacity, she managed outpatient services for seniors and cared for 100 high-risk older adults. As a faculty member at the University of Pennsylvania, she worked with a nationally-recognized transitional care program for high-risk older adults. She teaches clinical GNP students in Pennsylvania.



Speaker Disclosures:

Financial: M. Catherine Wollman is a visiting Professor with Chamberlain College of Nursing. She receives a speaking honorarium from PESI, Inc.

Non-financial: M. Catherine Wollman is a member of the Gerontological Advanced Practice Nurses Association.
Credits listed below are for full attendance at the live event only. After attendance has been verified, pre-registered attendees will receive an email from PESI Customer Service with the subject line, “Evaluation and Certificate” within one week. This email will contain a link to complete the seminar evaluation and allow attendees to print, email or download a certificate of completion if in full attendance. For those in partial attendance (arrived late or left early), a letter of attendance is available through that link and an adjusted certificate of completion reflecting partial credit will be issued within 30 days (if your board allows). Please see “live seminar schedule” for full attendance start and end times. NOTE: Boards do not allow credit for breaks or lunch.

If your profession is not listed, please contact your licensing board to determine your continuing education requirements and check for reciprocal approval. For other credit inquiries not specified below, or questions on home study credit availability, please contact cepesi@pesi.com or 800-844-8260 before the event.

Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of mental health professionals. As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your professions standards.

PESI, Inc. offers continuing education programs and products under the brand names PESI, PESI Healthcare, PESI Rehab and Psychotherapy Networker.




Nurses, Nurse Practitioners, and Clinical Nurse Specialists
American Nurses Credentialing Center Logo
PESI, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses in full attendance will earn 12.6 contact hours. Partial contact hours will be awarded for partial attendance.

California Nurses: PESI, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number 17118 for 12.5 contact hours. Full attendance is required. No partial contact hours will be issued for partial attendance.


Pharmacology Nurse Practitioners
This program offers 120 instructional minutes of pharmacology content which is designed to qualify for 2.0 contact hours toward your pharmacology requirement to receive credit. It is your responsibility to submit your certificate of successful completion and a copy of the seminar brochure to your licensing board.


Nursing Home Administrators
This educational offering has been reviewed by the National Continuing Education Review Service (NCERS) of the National Association of Long Term Care Administrator Boards (NAB) and approved for 12.5 clock hours and 12.5 participant hours. Full attendance is required; no partial credits will be offered for partial attendance.


Occupational Therapists & Occupational Therapy Assistants
AOTA Logo
PESI, Inc. is an AOTA Approved Provider of continuing education. Provider #: 3322. Full attendance at this course qualifies for 12.5 contact hours or 1.25 CEUs in the Category of Domain of OT and Occupational Therapy Process. Partial credit will be issued for partial attendance. The assignment of AOTA CEUs does not imply endorsement of specific course content, products, or clinical procedures by AOTA. Course Level: Intermediate.


Physical Therapists & Physical Therapist Assistants
This activity consists of 12.5 clock hours of instruction that is applicable for physical therapists. CE requirements for physical therapists vary per state/jurisdiction. Please retain the certificate of completion that you receive and use as proof of completion when required.

California Physical Therapists & Physical Therapist Assistants:
CA PT
PESI, Inc. is recognized by the Physical Therapy Board of California as an approval agency to approve providers. This lecture qualifies for 12.5 continuing competency hours.


Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME such as PESI. Physician assistants may receive a maximum of 12.5 hours for completing this program.

PESI, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. PESI, Inc. designates this live activity for a maximum of 12.5 AMA PRA Category 1 Credits™.


Speech-Language Pathologists
ASHA Logo

This course is offered for 1.25 ASHA CEUs (Intermediate level, Professional area).


Social Workers
ASWB Logo
PESI, Inc., #1062, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. PESI, Inc. maintains responsibility for this course. ACE provider approval period: January 27, 2017 - January 27, 2020. Social Workers completing this course receive 12.5 Clinical Practice continuing education credits. Course Level: Intermediate. Full attendance is required; no partial credits will be offered for partial attendance. A certificate of attendance will be awarded at the end of the program to social workers who complete the program evaluation.

California Social Workers: The California Board of Behavioral Sciences accepts CE programs that are approved by other approval agencies, including several that approve PESI and its programs. A full list of approval agencies accepted by the BBS can be found at www.bbs.ca.gov/licensees/cont_ed.html under “Where to find CE Courses.” This Intermediate level activity consists of 12.0 clock hours of continuing education instruction.


Other Professions
This activity qualifies for 760 minutes of instructional content as required by many national, state and local licensing boards and professional organizations. Save your course outline and certificate of completion, and contact your own board or organization for specific requirements.

Credit Card Required for online registration | Contact us to redeem Gift Certificates